16904537

Source:http://linkedlifedata.com/resource/pubmed/id/16904537

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006644, umls-concept:C0026336, umls-concept:C0026339, umls-concept:C0086418, umls-concept:C0376466, umls-concept:C1292733, umls-concept:C1545588
pubmed:issue	4
pubmed:dateCreated	2006-8-14
pubmed:databankReference	http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00184912
pubmed:abstractText	We studied whether caffeine impairs protection by ischemic preconditioning (IP) in humans.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8301365
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Annexin A5, http://linkedlifedata.com/resource/pubmed/chemical/Caffeine, http://linkedlifedata.com/resource/pubmed/chemical/Central Nervous System Stimulants, http://linkedlifedata.com/resource/pubmed/chemical/Organotechnetium Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Purinergic P1 Receptor Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Radiopharmaceuticals, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Purinergic P1, http://linkedlifedata.com/resource/pubmed/chemical/technetium Tc 99m annexin V
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	1558-3597
pubmed:author	pubmed-author:BoermanOtto COC, pubmed-author:BrouwerRene M H JRM, pubmed-author:JaspersRogierR, pubmed-author:OyenWim J GWJ, pubmed-author:RamakersBart PBP, pubmed-author:RiksenNiels PNP, pubmed-author:RongenGerard AGA, pubmed-author:SmitsPaulP, pubmed-author:SteinmetzNeilN, pubmed-author:ZhouZhigangZ
pubmed:issnType	Electronic
pubmed:day	15
pubmed:volume	48
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	700-7
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:16904537-Adult, pubmed-meshheading:16904537-Annexin A5, pubmed-meshheading:16904537-Caffeine, pubmed-meshheading:16904537-Central Nervous System Stimulants, pubmed-meshheading:16904537-Double-Blind Method, pubmed-meshheading:16904537-Humans, pubmed-meshheading:16904537-Ischemic Preconditioning, pubmed-meshheading:16904537-Male, pubmed-meshheading:16904537-Muscle, Skeletal, pubmed-meshheading:16904537-Organotechnetium Compounds, pubmed-meshheading:16904537-Purinergic P1 Receptor Antagonists, pubmed-meshheading:16904537-Radiopharmaceuticals, pubmed-meshheading:16904537-Receptors, Purinergic P1, pubmed-meshheading:16904537-Reperfusion Injury
pubmed:year	2006
pubmed:articleTitle	Caffeine prevents protection in two human models of ischemic preconditioning.
pubmed:affiliation	Department of Pharmacology-Toxicology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands. N.Riksen@aig.umcn.nl
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't